APA (7th ed.) Citation

J, M., M, M., E, P., V, B., S, R., E, D. P., . . . A, B. (2025). SLYMEC II study: Overall survival analysis of the impact of LVSI in apparent early stage endometrioid endometrial cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 51(7), 109750. https://doi.org/10.1016/j.ejso.2025.109750

Chicago Style (17th ed.) Citation

J, Mauro, et al. "SLYMEC II Study: Overall Survival Analysis of the Impact of LVSI in Apparent Early Stage Endometrioid Endometrial Cancer." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 51, no. 7 (2025): 109750. https://doi.org/10.1016/j.ejso.2025.109750.

MLA (9th ed.) Citation

J, Mauro, et al. "SLYMEC II Study: Overall Survival Analysis of the Impact of LVSI in Apparent Early Stage Endometrioid Endometrial Cancer." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 51, no. 7, 2025, p. 109750, https://doi.org/10.1016/j.ejso.2025.109750.